FDA to Authorize Pfizer Covid Vaccine Booster Dose for Older, At-Risk Americans - Bloomberg
People over age 65 and adults at high risk of severe Covid-19 can receive a booster dose of the Pfizer Inc.-BioNTech SE vaccine, the Food and Drug Administration said, opening a new and more controversial phase of the U.S. immunization campaign.
People over age 65 and adults at high risk of severe Covid-19 can receive a booster dose of the Pfizer Inc.-BioNTech SE vaccine, the Food and Drug Administration said, opening a new and more controversial phase of the U.S. immunization campaign.